Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Oilminerdeluxe on Dec 15, 2021 7:22am

Q about BTD

My buddy and I had a little query (Hello Jens). I read somewhere: "The criteria for breakthrough therapy designation require preliminary clinical evidence that demonstrates the drug may have substantial improvement on at least one clinically significant endpoint over available therapy."

Does that mean we can apply for a BTD approval with the 3 month numbers if they are good enough? Or do we have to wait a full year (12-15 months) before such a thing is possible? Since the optimized patients still have a long way to go until they are at 12 months, we sort of debated if we have to wait another ice age, or if we could already be in a possible time zone where TLT can apply for BTD any day now?

Anyone with a thought to share on this?
Thanks.
Comment by wildbird1 on Dec 15, 2021 8:30am
Oilminerdeluxe..Good question. On the fda.gov/regulatory-information/frequently asked questions-BTD (#23)... (Quote) The review division(FDA) will make a recommendation as to whether a request for a Breakthrough Designation is appropriate, may be to preliminary, or does not currently meet the criteria for BTD. (End of quote). Meaning it is the FDA that decide if it is to soon or not. On year ...more  
Comment by Rumpl3StiltSkin on Dec 15, 2021 9:30am
I think it is clear if the CR data continues to come in as good as it has, so far, we'll have a path to BTD soon. Another cohort of patient data, in the next Quarterly? Very possible.
Comment by Oilminerdeluxe on Dec 15, 2021 9:54am
Thank you, Rumpl and Wildbird. Maybe the wait is not as long as I feared. So if we have a solid update next time, then we should be well on our way.
Comment by greaterfoolFred on Dec 15, 2021 10:51am
I am sure that the FDA will want to see results from patients treated at several different locations.  How many locations are now treating patients?  I only know of one.  Or have I missed something?  Wouldn't there be a news release for treatment in a new site?  Our day will come, but let's not create false expectations.  Good luck all.
Comment by Rumpl3StiltSkin on Dec 15, 2021 11:05am
Yep, I'm betting, literally, that the numbers wil be solid next Quarterly, which leads to the discussion on BTD with the FDA. Which will probably be brought up by the FDA. :-)
Comment by wildbird1 on Dec 15, 2021 11:06am
Forgot to mention.... Last year FDA gave TLT Fast-Track Designation with only 12 patients treated and a CR%(Complete Response ) of just 25%. Today TLT has 18 Optimized patients treated (50% more patients treated than last year 12 patients), and a CR% potential of 94.4% (278% more CR% than than last year 25% necessary for Fast-track designation). The FDA can give BTD(Breakthrough Designation) if ...more  
Comment by enriquesuave on Dec 15, 2021 12:43pm
Nice post Wildbird.  I believe that the company has stated that after 25 patients they would file for BTD, and recently Vera commented "soon" .  So clearly they can now as they have perhaps received data from patients 24 and 25 who have hit at least 90 days.  We have strong efficacy signals and also also pointing towards strong durable efficacy results IMO.  That may ...more  
Comment by patience69 on Dec 15, 2021 12:55pm
BTD would be awesome & so would moving onto another exchange. Isn't the most important pending event really some sort of a partner? Maybe news will just be bang bang bang as some sort of a funding source will likely be necessary to let any of these things happen. I don't know about you but I bet that those negotiations are ongoing. All my best guess mind you 
Comment by CancerSlayer on Dec 15, 2021 4:19pm
Enriquesuave wrote: "Nice post Wildbird.  I believe that the company has stated that after 25 patients they would file for BTD, and recently Vera commented "soon" .  So clearly they can now as they have perhaps received data from patients 24 and 25 who have hit at least 90 days.  We have strong efficacy signals and also also pointing towards strong durable efficacy ...more  
Comment by Infinity on Dec 16, 2021 5:08am
I agree with Enrique,  we are close to submiting the application for Break through designation.  I tried to gather some info from the FDA web page re BTD application process.  Appears straightforward.  The qualifer would be a significant "UNMET Demand" should exist for this type of cure or treatment.  I believe TLT would meet this criteria of unmet demand and the ...more  
Comment by robertshaw on Dec 16, 2021 9:00am
Agree with Infiity. It's in fact the great honor of FDA to grant BTD to us....ASAP ( I amexpecting before Next May). Otherwise I see no difference betwween FDA and our old friends--Blowjobjoe's bosses.
Comment by robertshaw on Dec 16, 2021 9:07am
No other medical treatment technology in human history could  ever achieve the height of TLD1433.  It's also "great hornor" of  blojobjoe's bosses that almost beated this brilliant technology to death... but, anyway, we survived. So, it's quite safe to say now"Blowjobjoe's bosses '  days are numbered..."
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250